IBRX icon

IBRX - Keuangan

Pre-MarketPre-Market

ImmunityBio, Inc. Common Stock

$7.05Price Down$0.05 (-0.70%)
Selasa, 10 November 2026 20:41 WIB
$7.1Price Down$1.53 (-17.73%)
Selasa, 10 November 2026 03:59 WIB
iconPerforma Harga
Harga kembali 1 minggu-14.92%
Harga kembali 1 Bulan-32.73%
Harga kembali 3 Bulan-5.61%
Harga kembali 6 Bulan-
Harga Tertinggi (52 Minggu)10.97
Harga Terendah (52 Minggu)6.65
Latar Belakang Perusahaan
Perusahaan bioteknologi yang mengembangkan terapi imun (immunotherapy) dan pengobatan kanker berbasis sistem kekebalan tubuh, termasuk terapi untuk kanker kandung kemih dan berbagai jenis kanker lainnya.

Cashflow Statement

20252024202320222021

Operating Cash Flow

(304.94M)(391.24M)(366.76M)(337.51M)(274.42M)

Investing Cash Flow

(149.80M)(12.25M)(30.47M)27.30M(84.89M)

Financing Cash Flow

400.24M281.63M558.34M233.61M505.44M

Net Change In Cash

(54.50M)(121.85M)161.11M(76.60M)146.14M

Saham Terkait